Relmada Therapeutics
RLMD
$0.42
Share price
-5.76%
Change (1 day)
-95.57%
Change (1 year)
Categories
Relmada Therapeutics (RLMD) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : A$13.04 Million
According to Relmada Therapeutics's latest financial reports the company's total liabilities are A$13.04 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Relmada Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | A$18.32 M | -11.8% |
| 2021-12-31 | A$20.77 M | 26.74% |
| 2020-12-31 | A$16.39 M | |
| 2019-06-30 | A$3.71 M | -67.9% |
| 2018-06-30 | A$11.56 M | 545.59% |
| 2017-06-30 | A$1.79 M | -58.21% |
| 2016-06-30 | A$4.28 M | -78.9% |
| 2015-06-30 | A$20.3 M | -28.83% |
| 2014-06-30 | A$28.53 M | |
| 2013-08-31 | A$0.03 M | 455.74% |
| 2012-08-31 | A$0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | A$0.61 B | 4,642.20% | 🇮🇱 Israel |
 | A$2.33 B | 17,802.37% | 🇺🇸 USA |